Market Research Logo

Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Forecast to 2022

Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO) - Global Forecast to 2022

“PDX models market is projected to grow at a CAGR of 16.7%”
The global PDX models market is estimated to grow at a CAGR of 16.7% from 2017 to 2022, to reach USD 167.6 million. The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.

“The respiratory tumor models segment is projected to grow at the highest CAGR during the forecast period”
Based on tumor type, the PDX models market is segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models such as head & neck cancer, sarcoma, and melanoma. During the forecast period, the respiratory tumor models segment is expected to register the highest CAGR. Growth in this segment is mainly driven by the increasing focus of market players on generating lung cancer PDX models, which could lead to a breakthrough in lung cancer treatment, as lung cancer is the leading cause of cancer-related deaths across the globe.

“Asia Pacific to witness the highest growth during the forecast period”
Asia Pacific is expected to grow at the highest CAGR in the global PDX models market during the forecast period of 2017–2022. Strong research expenditure and the well-structured CRO industry in China, growth in biomedical & medical research in Japan, rising pharmaceutical R&D expenditure in India, and rising translational and biomedical research in Singapore are expected to drive the market growth during the forecast period.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–55%, Tier 25%, and Tier 20%
• By Designation – C-level–43%, Director Level–32%, Others–25%
• By Region – North America–38%, Europe–23%, Asia-Pacific–29%, RoW–10%

The various players in the PDX models market include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International, Inc. (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd. (China), Xentech (France), Horizon Discovery Group PLC (UK), Urolead (France), and Explora BioLabs (US).

Research Coverage:
The report analyzes the PDX models market and aims at estimating the market size and the future growth potential of this market based on various segments such as type, tumor type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global PDX models market
• Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global PDX models market
• Market Development: Comprehensive information about the lucrative emerging markets by type, tumor type, application, end user, and region
• Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global PDX models market
• Competitive Assessment: In-depth assessment of growth strategies, products, and services of leading players in the market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
    • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
    • MARKET SIZE ESTIMATION METHODOLOGY
    • MARKET FORECAST METHODOLOGY
    • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • PDX MODELS MARKET OVERVIEW
    • REGIONAL ANALYSIS: GLOBAL PDX MODELS MARKET, BY END USER
    • GLOBAL PDX MODELS MARKET, BY TUMOR TYPE, 2017 & 2022
    • REGIONAL SNAPSHOT OF THE GLOBAL PDX MODELS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITY
      • CHALLENGE
  • PDX MODELS MARKET, BY TYPE
    • INTRODUCTION
      • Table GLOBAL PDX MODELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
    • MICE MODELS
      • Table PDX MICE MODELS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • RAT MODELS
      • Table PDX RAT MODELS MARKET, BY REGION, 2015-2022 (USD THOUSAND)
  • PDX MODELS MARKET, BY TUMOR TYPE
    • INTRODUCTION
      • Table GLOBAL PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD MILLION)
    • GASTROINTESTINAL TUMOR MODELS
      • Table GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • GYNECOLOGICAL TUMOR MODELS
      • Table GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • RESPIRATORY TUMOR MODELS
      • Table RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • UROLOGICAL TUMOR MODELS
      • Table UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2015-2022 (USD THOUSAND)
    • HEMATOLOGICAL TUMOR MODELS
      • Table HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2015-2022 (USD THOUSAND)
    • OTHER TUMOR MODELS
      • Table OTHER TUMOR MODELS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • PDX MODELS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table GLOBAL PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
    • PRECLINICAL DRUG DEVELOPMENT AND BASIC CANCER RESEARCH
      • Table PDX MODELS MARKET FOR PRECLINICAL DRUG DEVELOPMENT AND BASIC CANCER RESEARCH, BY REGION, 2015-2022 (USD MILLION)
    • BIOMARKER ANALYSIS
      • Table PDX MODELS MARKET FOR BIOMARKER ANALYSIS, BY REGION, 2015-2022 (USD MILLION)
  • PDX MODELS MARKET, BY END USER
    • INTRODUCTION
      • Table GLOBAL PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • Table PDX MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • Table PDX MODELS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTIONS
      • Table PDX MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2015-2022 (USD MILLION)
  • PDX MODELS MARKET, BY REGION
    • INTRODUCTION
      • Table PDX MODELS MARKET, BY REGION, 2015-2022 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: PDX MODELS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: PDX MODELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
      • Table NORTH AMERICA: PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • US
        • Table US: PDX MODELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table US: PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD MILLION)
        • Table US: PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table US: PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
      • CANADA
        • Table CANADA: PDX MODELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD MILLION)
        • Table CANADA: PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table CANADA: PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • EUROPE
      • FOCUS ON CANCER RESEARCH AND TREATMENT
      • GERMANY: GROWTH OF THE BIOTECH SECTOR
      • SPAIN: AVAILABILITY OF VENTURE FUNDING FOR LIFE SCIENCES
      • ITALY: GROWTH OF THE BIOTECH, PHARMA SECTORS
      • RISING RESEARCH INVESTMENTS IN SWEDEN, AUSTRIA, AND DENMARK
        • Table EUROPE: PDX MODELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table EUROPE: PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD MILLION)
        • Table EUROPE: PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table EUROPE: PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • ASIA PACIFIC
      • RISING FOCUS ON PRECISION MEDICINE AND PERSONALIZED MEDICINE IN CHINA
      • STRONG RESEARCH EXPENDITURE AND WELL-STRUCTURED CROS INDUSTRY IN CHINA
      • GROWING FOCUS OF PHARMACEUTICAL AND ANIMAL RESEARCH MODEL SUPPLIERS ON CHINA
      • PUBLIC AND PRIVATE INVESTMENTS IN CHINA'S LIFE SCIENCES SECTOR
      • INITIATIVES TO REDUCE LONG APPROVAL TIMES IN CHINA
      • INTELLECTUAL PROPERTY (IP) BREACHES, A CHALLENGE FOR MARKET GROWTH IN CHINA
      • JAPAN: GROWTH IN BIOMEDICAL AND MEDICAL RESEARCH
        • Table JAPAN: SIGNIFICANT PARTNERSHIPS
      • INDIA: RISING R&D EXPENDITURE
      • INFRASTRUCTURAL LIMITATIONS IN INDIA
      • AVAILABILITY OF FUNDING FOR BIOMEDICAL RESEARCH IN AUSTRALIA
      • RISING TRANSLATIONAL AND BIOMEDICAL RESEARCH IN SINGAPORE
      • RISING PHARMACEUTICAL AND BIOTECHNOLOGY R&D IN KOREA
        • Table ASIA PACIFIC: PDX MODELS MARKET, BY TYPE, 2015-2022 (USD MILLION)
        • Table ASIA PACIFIC: PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD MILLION)
        • Table ASIA PACIFIC: PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table ASIA PACIFIC: PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • RISING R&D IN BRAZIL
      • GROWTH OF THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES IN SAUDI ARABIA AND THE UAE
        • Table ROW: PDX MODELS MARKET, BY TYPE, 2015-2022 (USD THOUSAND)
        • Table ROW: PDX MODELS MARKET, BY TUMOR TYPE, 2015-2022 (USD THOUSAND)
        • Table ROW: PDX MODELS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
        • Table ROW: PDX MODELS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MARKET RANKING ANALYSIS
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • EMERGING COMPANIES
      • DYNAMIC DIFFERENTIATORS
    • COMPETITIVE BENCHMARKING
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
  • COMPANY PROFILES
    • CROWN BIOSCIENCE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • THE JACKSON LABORATORY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • CHAMPIONS ONCOLOGY, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • WUXI APPTEC (GROUP OF SUBSIDIARIES UNDER WUXI PHARMATEC)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ONCODESIGN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • HORIZON DISCOVERY GROUP PLC (SAGE LABS, INC.)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • PHARMATEST SERVICES LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • HERA BIOLABS
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • EPO BERLIN-BUCH GMBH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • XENTECH
      • BUSINESS OVERVIEW
      • PRODUCTS AND SERVICES OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • UROLEAD
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report